Advanced Cancer Therapy in India: The Promise of Enfortumab Vedotin 20/30 mg

Enfortumab vedotin 20\/30 mg is an innovative treatment for advanced urothelial carcinoma. Targeting the Nectin-4 protein, it delivers a cytotoxic agent directly to cancer cells, reducing toxicity to healthy tissues. Available in India, Enfortumab vedotin 20\/30 mg in India has shown improved surviv

0 views • 10 slides